| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |